One drink a day after heart attack? new study puts it to the test
NCT ID NCT05920629
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether moderate alcohol consumption (about one drink per day) affects heart function in people who recently had a heart attack. 220 participants will either drink moderately or abstain for 3 months, and their heart pumping ability will be measured by ultrasound. The goal is to see if there is any benefit or harm to the heart's recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- alcohol consumption (behavioral intervention)
- What this could lead to
- If it works, this could show whether moderate drinking helps or harms heart recovery after a heart attack, guiding future lifestyle advice.
- What could go wrong
- This is a small, short-term study (3 months) with only 220 participants, so results may not apply broadly. It cannot prove long-term effects or safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 220 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2023
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Hospitalization for acute ST-elevation MI (STEMI) or non ST-elevation MI (NSTEMI) within 365 days prior to screening * Men and women aged ≥18 years who are capable and willing to provide consent * ECG ischemic changes, such as persistent or dynamic ST-segment deviation * Evidence of positive high-sensitive troponin * Confirmation of coronary heart disease aetiology by angiography * Capacity to complete study visits with strict adherence to the protocol assignment * Self-reported average alcohol consumption of between 1 and 28 standard units per week in the 12 months prior to the index hospitalization. Exclusion Criteria: * High alcohol consumption, defined as an average of \>28 alcoholic standard units/week in the 12 months prior to the index hospitalization * Alcohol use disorder (AUDIT score \>20 at screening) * History of alcohol or substance abuse * Naïve to alcohol consumption * Light alcohol consumption (\<1 standard units by week) * Prior severe heart failure (NYHA III-IV) * Severe LV dysfunction at screening (\<30%) * History of gastric ulcer or gastro-intestinal bleeding * Serious chronic liver disease or liver test elevation (\> 3 times upper limit normal range) * Personal history of any colon or liver cancer * Any active malignancy (less than 5 years or ongoing treatment) * Estimated glomerular filtration rate 15 ml/min/1.73m² or end-stage renal disease * Any medication (investigator's discretion) making study participation impractical or precluding required follow-up * History of organ transplant * Participation in another trial testing intervention on similar CV outcomes (investigator's discretion) * Any medical, geographic, or social factor making study participation impractical or precluding required follow-up. * Pregnant, breastfeeding or planning to become pregnant within 12 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Myocardial infarction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre hospitalier universitaire vaudois
RECRUITINGLausanne, Canton of Vaud, 1005, Switzerland
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, 1205, Switzerland
-
Inselspital
RECRUITINGBern, Canton of Bern, 3010, Switzerland
-
Universitätsspital Basel
RECRUITINGBasel, Basel, 4031, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Pharmacist and coach team takes aim at blood pressure after stroke
- Broken heart syndrome: is it as deadly as a heart attack?
- Fat graft may mend heart scars after a heart attack
- A simple breath test after a heart attack could prevent dangerous bleeding
- A simple ultrasound test may sharpen heart attack risk predictions